TIGIT and acute myeloid leukemia: Wang et al. conducted a study on patients with AML and found increased PD-1 and TIGIT expression as well as decreased CD226 expression in peripheral blood CD8+ T cells compared with those of healthy individuals, and these cells were crucial biomarkers of poor clinical prognosis [112].